Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$0.67 - $1.51 $10,787 - $24,311
-16,100 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$0.75 - $1.1 $278,820 - $408,937
-371,761 Reduced 95.85%
16,100 $12,000
Q1 2021

May 17, 2021

BUY
$0.96 - $1.74 $215,998 - $391,496
224,998 Added 138.15%
387,861 $407,000
Q4 2020

Feb 16, 2021

BUY
$0.76 - $1.47 $123,775 - $239,408
162,863 New
162,863 $221,000
Q1 2019

May 15, 2019

SELL
$0.6 - $1.41 $21,300 - $50,055
-35,500 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$0.53 - $1.11 $18,815 - $39,405
35,500 New
35,500 $21,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $134M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.